@article{
 title = {Considerations for use of ketamine to treat depression in Australia and New Zealand},
 type = {article},
 year = {2019},
 identifiers = {[object Object]},
 pages = {000486741986651},
 websites = {http://journals.sagepub.com/doi/10.1177/0004867419866510},
 month = {7},
 publisher = {SAGE PublicationsSage UK: London, England},
 day = {31},
 id = {aec86d0d-8dfb-3fbc-86ab-3b210f0adcd0},
 created = {2019-08-08T16:44:32.604Z},
 accessed = {2019-08-08},
 file_attached = {false},
 profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},
 group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},
 last_modified = {2019-08-22T17:17:07.143Z},
 tags = {CA,Disc:Psychopharmacology},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {false},
 hidden = {false},
 private_publication = {false},
 bibtype = {article},
 author = {Bayes, Adam and Dong, Vanessa and Loo, Colleen},
 journal = {Australian & New Zealand Journal of Psychiatry}
}

{"_id":"G8pkJxcMQpLPhMutF","bibbaseid":"bayes-dong-loo-considerationsforuseofketaminetotreatdepressioninaustraliaandnewzealand-2019","authorIDs":[],"author_short":["Bayes, A.","Dong, V.","Loo, C."],"bibdata":{"title":"Considerations for use of ketamine to treat depression in Australia and New Zealand","type":"article","year":"2019","identifiers":"[object Object]","pages":"000486741986651","websites":"http://journals.sagepub.com/doi/10.1177/0004867419866510","month":"7","publisher":"SAGE PublicationsSage UK: London, England","day":"31","id":"aec86d0d-8dfb-3fbc-86ab-3b210f0adcd0","created":"2019-08-08T16:44:32.604Z","accessed":"2019-08-08","file_attached":false,"profile_id":"38c6dbcb-2394-3f18-9217-58d777c08c69","group_id":"d9389c6c-8ab5-3b8b-86ed-33db09ca0198","last_modified":"2019-08-22T17:17:07.143Z","tags":"CA,Disc:Psychopharmacology","read":false,"starred":false,"authored":false,"confirmed":false,"hidden":false,"private_publication":false,"bibtype":"article","author":"Bayes, Adam and Dong, Vanessa and Loo, Colleen","journal":"Australian & New Zealand Journal of Psychiatry","bibtex":"@article{\n title = {Considerations for use of ketamine to treat depression in Australia and New Zealand},\n type = {article},\n year = {2019},\n identifiers = {[object Object]},\n pages = {000486741986651},\n websites = {http://journals.sagepub.com/doi/10.1177/0004867419866510},\n month = {7},\n publisher = {SAGE PublicationsSage UK: London, England},\n day = {31},\n id = {aec86d0d-8dfb-3fbc-86ab-3b210f0adcd0},\n created = {2019-08-08T16:44:32.604Z},\n accessed = {2019-08-08},\n file_attached = {false},\n profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},\n group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},\n last_modified = {2019-08-22T17:17:07.143Z},\n tags = {CA,Disc:Psychopharmacology},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {false},\n hidden = {false},\n private_publication = {false},\n bibtype = {article},\n author = {Bayes, Adam and Dong, Vanessa and Loo, Colleen},\n journal = {Australian & New Zealand Journal of Psychiatry}\n}","author_short":["Bayes, A.","Dong, V.","Loo, C."],"urls":{"Website":"http://journals.sagepub.com/doi/10.1177/0004867419866510"},"bibbaseid":"bayes-dong-loo-considerationsforuseofketaminetotreatdepressioninaustraliaandnewzealand-2019","role":"author","downloads":0},"bibtype":"article","creationDate":"2019-08-09T20:23:52.055Z","downloads":0,"keywords":[],"search_terms":["considerations","use","ketamine","treat","depression","australia","new","zealand","bayes","dong","loo"],"title":"Considerations for use of ketamine to treat depression in Australia and New Zealand","year":2019}